70,199 Shares in Agilent Technologies, Inc. $A Bought by Nykredit A S

Nykredit A S purchased a new stake in Agilent Technologies, Inc. (NYSE:A) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 70,199 shares of the medical research company’s stock, valued at approximately $9,325,000.

Other large investors have also bought and sold shares of the company. State Street Corp lifted its position in shares of Agilent Technologies by 1.9% during the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after buying an additional 241,029 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Agilent Technologies by 2.7% during the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after acquiring an additional 198,253 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after acquiring an additional 25,139 shares during the last quarter. Deutsche Bank AG lifted its holdings in Agilent Technologies by 17.1% during the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after acquiring an additional 1,024,516 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after purchasing an additional 2,440,360 shares during the last quarter.

Agilent Technologies Stock Up 0.4%

Agilent Technologies stock opened at $150.60 on Friday. The firm has a 50 day simple moving average of $142.27 and a 200 day simple moving average of $127.87. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $163.75. The firm has a market capitalization of $42.46 billion, a price-to-earnings ratio of 29.65, a P/E/G ratio of 2.30 and a beta of 1.24.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.13. The firm had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The business’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 6.2 earnings per share for the current year.

Analyst Ratings Changes

A has been the subject of a number of research analyst reports. Piper Sandler started coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective for the company. Wells Fargo & Company lowered their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Stifel Nicolaus upped their price objective on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. Barclays increased their price objective on Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a report on Thursday, August 27th. Finally, Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $170.33.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.